| Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use B Dean, S Sundram, R Bradbury, E Scarr, D Copolov Neuroscience 103 (1), 9-15, 2001 | 465 | 2001 |
| Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ... Molecular psychiatry 23 (5), 1261-1269, 2018 | 274 | 2018 |
| Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder E Scarr, G Pavey, S Sundram, A MacKinnon, B Dean Bipolar Disorders 5 (4), 257-264, 2003 | 130 | 2003 |
| Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia E Scarr, TF Cowie, S Kanellakis, S Sundram, C Pantelis, B Dean Molecular psychiatry 14 (11), 1017, 2009 | 124 | 2009 |
| Cannabis and neurodevelopment: implications for psychiatric disorders S Sundram Human Psychopharmacology: Clinical and Experimental 21 (4), 245-254, 2006 | 109 | 2006 |
| Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia E Scarr, S Sundram, D Keriakous, B Dean Biological psychiatry 61 (10), 1161-1170, 2007 | 99 | 2007 |
| Accelerated gray and white matter deterioration with age in schizophrenia VL Cropley, P Klauser, RK Lenroot, J Bruggemann, S Sundram, ... American Journal of Psychiatry 174 (3), 286-295, 2017 | 94 | 2017 |
| A brief dyadic group based psychoeducation program improves relapse rates in recently remitted bipolar disorder: a pilot randomised controlled trial R D'Souza, D Piskulic, S Sundram Journal of Affective Disorders 120 (1-3), 272-276, 2010 | 88 | 2010 |
| Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects AS Gibbons, E Scarr, C McLean, S Sundram, B Dean Journal of affective disorders 116 (3), 184-191, 2009 | 85 | 2009 |
| Mirtazapine add‐on therapy in the treatment of schizophrenia with atypical antipsychotics: a double‐blind, randomised, placebo‐controlled clinical trial M Berk, CS Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, ... Human Psychopharmacology: Clinical and Experimental 24 (3), 233-238, 2009 | 80 | 2009 |
| Mental disorders in asylum seekers: The role of the refugee determination process and employment DC Hocking, GA Kennedy, S Sundram The Journal of nervous and mental disease 203 (1), 28-32, 2015 | 70 | 2015 |
| Neuregulin-1 and schizophrenia in the genome-wide association study era MS Mostaid, D Lloyd, B Liberg, S Sundram, A Pereira, C Pantelis, T Karl, ... Neuroscience & Biobehavioral Reviews 68, 387-409, 2016 | 54 | 2016 |
| Are patients with schizophrenia impaired in processing non-emotional features of human faces? H Darke, JS Peterman, S Park, S Sundram, O Carter Frontiers in psychology 4, 529, 2013 | 52 | 2013 |
| The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes R Wells, V Swaminathan, S Sundram, D Weinberg, J Bruggemann, ... NPJ schizophrenia 1 (1), 1-8, 2015 | 50 | 2015 |
| Clozapine decreases [3 H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens S Sundram, D Copolov, B Dean Naunyn-Schmiedeberg's archives of pharmacology 371 (5), 428-433, 2005 | 49 | 2005 |
| Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder B Dean, A Digney, S Sundram, E Thomas, E Scarr Psychiatry research 158 (1), 75-78, 2008 | 35 | 2008 |
| Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia MS Mostaid, SG Mancuso, C Liu, S Sundram, C Pantelis, IP Everall, ... Translational psychiatry 7 (1), e1004-e1004, 2017 | 32 | 2017 |
| Psychosocial responses to disaster: An Asian perspective S Sundram, ME Karim, L Ladrido-Ignacio, A Maramis, KA Mufti, ... Asian Journal of Psychiatry 1 (1), 7-14, 2008 | 28 | 2008 |
| Widespread volumetric reductions in schizophrenia and schizoaffective patients displaying compromised cognitive abilities TE Van Rheenen, V Cropley, A Zalesky, C Bousman, R Wells, ... Schizophrenia bulletin 44 (3), 560-574, 2018 | 27 | 2018 |
| Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs A Pereira, A Sugiharto-Winarno, B Zhang, P Malcolm, G Fink, S Sundram International Journal of Neuropsychopharmacology 15 (8), 1149-1160, 2012 | 26 | 2012 |
Brian DeanFlorey Institute for Neuroscience and Mental HealthVerified email at florey.edu.au
